Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Sep;76(3):667-78.
doi: 10.1124/mol.109.055830. Epub 2009 Jun 26.

Dual mechanisms of sHA 14-1 in inducing cell death through endoplasmic reticulum and mitochondria

Affiliations

Dual mechanisms of sHA 14-1 in inducing cell death through endoplasmic reticulum and mitochondria

David Hermanson et al. Mol Pharmacol. 2009 Sep.

Abstract

HA 14-1 is a small-molecule Bcl-2 antagonist that promotes apoptosis in malignant cells, but its mechanism of action is not well defined. We recently reported that HA 14-1 has a half-life of only 15 min in vitro, which led us to develop a stable analog of HA 14-1 (sHA 14-1). The current study characterizes its mode of action. Because of the antiapoptotic function of Bcl-2 family proteins on the endoplasmic reticulum (ER) and mitochondria, the effect of sHA 14-1 on both organelles was evaluated. sHA 14-1 induced ER calcium release in human leukemic cells within 1 min, followed by induction of the ER stress-inducible transcription factor ATF4. Similar kinetics and stronger intensity of ER calcium release were induced by the sarcoendoplasmic reticulum Ca(2+)-ATPase (SERCA) inhibitor thapsigargin, accompanied by similar kinetics and intensity of ATF4 induction. sHA 14-1 directly inhibited SERCA enzymatic activity but had no effect on the inositol triphosphate receptor. Evaluation of the mitochondrial pathway showed that sHA 14-1 triggered a loss of mitochondrial transmembrane potential (Delta psi m) and weak caspase-9 activation, whereas thapsigargin had no effect. (R)-4-(3-Dimethylamino-1-phenylsulfanylmethyl-propylamino)-N-{4-[4-(4'-chloro-biphenyl-2-ylmethyl)-piperazin-1-yl]-benzoyl}-3-nitrobenzenesulfonamide (ABT-737), a well established small-molecule Bcl-2 antagonist, rapidly induced loss of Delta psi m and caspase-9 activation but had no effect on the ER. The pan-caspase inhibitor N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl ketone had some protective effect on sHA 14-1-induced cell death. These collective results suggest a unique dual targeting mechanism of sHA 14-1 on the apoptotic resistance machinery of tumor cells that includes antiapoptotic Bcl-2 family proteins and SERCA proteins.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Structure of the compounds used in the present study and IC50 data for sHA 14-1. A, chemical structures of sHA 14-1, isHA 14-1, ABT-737, thapsigargin, and HA 14-1. As described under Materials and Methods, isHA 14-1 is an inactive variant of sHA 14-1. B, RS4;11, BLIN-1, and NALM-6 were incubated with various concentrations of sHA 14-1 for 18 h, and Annexin V-/PI- viable cells were quantified by flow cytometry. Each condition represents the mean ± S.D. of triplicate values. The results are representative of multiple experiments.
Fig. 2.
Fig. 2.
sHA 14-1 induces ER calcium release. NALM-6 (A, C, E, and G) and JURKAT (B, D, F, and H) were preloaded with Fura-2AM for 30 min. The cells were then washed, and fluorescent changes at excitation wavelengths of 340 and 380 nm were monitored on a dual-wavelength fluorometer. Data in A and B show the relative extent of cytosolic [Ca2+] changes after a 10-min incubation with the indicated concentrations of sHA 14-1 (normalized to the maximum cytosolic [Ca2+] increase induced by sHA 14-1 treatment). Data are mean ± S.D. (n = 3 for each conditions). Data in C to H show real-time changes in cytosolic [Ca2+] in cells treated with DMSO, 1 μM thapsigargin, 100 μM sHA 14-1, or 100 μM isHA 14-1. The gray tracings indicate that thapsigargin was added 10 min after the initial addition of DMSO (C and D), sHA 14-1 (E and F), or isHA 14-1 (G and H). The results are representative of three separate experiments.
Fig. 3.
Fig. 3.
Cytosolic [Ca2+] is an essential factor for sHA 14-1-induced cytotoxicity and sHA 14-1 directly targets the ER. A, untreated NALM-6 cells (black solid bar) or cells pretreated for 30 min with 5 μM EGTA-AM (gray bar) were incubated with the indicated concentrations of sHA 14-1. Relative cell viability was determined at 24 h by the Cell Titer-Blue cytotoxicity assay. Data are mean ± S.D. (n = 3 for each condition). Results are representative of three separate experiments. **, p < 0.01; ***, p < 0.0001. B, time course of Ca2+ uptake into intracellular Ca2+ stores in control cells (▪) and cells pretreated (5 min) with sHA 14-1 (50 μM,▴). Data are expressed relative to the final time point intracellular Ca2+ content. C and D, Ca2+ release from permeabilized NALM-6 cells loaded to steady state with 45Ca2+ induced by various concentrations of sHA 14-1 (C) or IP3 (D). Data are expressed relative to the zero time point before addition of ATP. Data are mean ± S.D. (n = 3 for each conditions). The results are representative of two separate experiments.
Fig. 4.
Fig. 4.
sHA 14-1 does not disrupt the function of the endoplasmic reticulum IP3R. A, parental (black bar) and IP3R-deficient (gray bar) DT-40 chicken lymphoma cells were incubated with the indicated concentrations of sHA 14-1, and relative cell viability was determined after 24 h by the Cell TiterBlue cytotoxicity assay. B, parental (black column) and IP3R-deficient (gray column) DT-40 chicken lymphoma cells were preloaded with Fura-2AM and treated with sHA 14-1 at indicated concentrations. Relative calcium release was measured using fluorescent changes at excitation wavelengths of 340 and 380 nm monitored on a dual-wavelength fluorometer and normalized to the amount of calcium release by thapsigarin in parental cells at the concentration of 1 μM. Data are mean ± S.D. (n = 3 for each conditions). None of the difference in calcium release in parental and IP3R-deficient cells is statistically significant (P > 0.05). The results are representative of three separate experiments.
Fig. 5.
Fig. 5.
sHA 14-1 inhibits SERCA enzymatic activity. NALM-6 (A) and JURKAT (B) cells were preloaded with Fura-2AM for 30 min. The cells were then incubated with 100 nM thapsigargin (+), the minimal concentration to induce full Ca2+ release, and increasing concentrations of sHA 14-1, as shown in the grid below the figures. Calcium release was quantified using fluorescent changes at excitation wavelengths of 340 and 380 nm monitored on a dual-wavelength fluorometer. Data are mean ± S.D. (n = 3 for each conditions). *, p < 0.05; **, p < 0.01; ***, p < 0.0001 compared with the quantity of calcium released by TG alone. C, increasing concentrations of sHA 14-1 were incubated for 10 min at 37°C with SR membrane fractions purified from rabbit skeletal muscle. Rabbit skeletal muscle Ca2+ ATPase activity (corresponding to SERCA 1A) was measured using the phosphate liberation assay, as described previously (Wootton and Michelangeli, 2006). Data are mean ± S.D. (n = 3 for each conditions). D, increasing concentrations of sHA 14-1 were incubated for 10 min at 37°C with pig brain microsomes. Ca2+ ATPase activity in these membranes (corresponding to SERCA 2B) was measured using a phosphate liberation assay, as described previously. Data are mean ± S.D. (n = 3 for each conditions). E, a SERCA sample (99%, 20 μg) was analyzed for the presence of Bcl-2 protein by Western blot with NALM-6 protein lysate (0.2, 1, and 5 μg) as a positive control. The results are representative of three separate experiments.
Fig. 6.
Fig. 6.
sHA 14-1 induces ER stress. NALM-6 cells were incubated with 1 μM TG or 50 μM sHA 14-1 for the indicated times (A) or with 1 μM thapsigargin and the indicated concentrations of sHA 14-1 for 2 h (B). RS4;11 cells were incubated with the indicated compounds and concentrations for 2 h (C). DMSO (2 h) was used as a negative control. The cells were then lysed and Western-blotted for detection of ATF4 and cleaved caspase-9 (Casp-9) as described under Materials and Methods. β-Tubulin (A and B), or AKT (C) were used as loading controls. The results are representative of three separate experiments.
Fig. 7.
Fig. 7.
sHA 14-1 induces loss of Δψm but no detectable cytochrome c release by flow cytometry. A, NALM-6 cells were incubated with sHA 14-1 or isHA 14-1 at 50 μM (dashed line) or 100 μM (solid line) or ABT-737 at 5 μM (dashed line) or 10 μM (solid line) for 8 h. B, RS4;11 cells were incubated for 8 h with 50 μM (dashed line) or 100 μM (solid line) sHA 14-1 or for 2 h with 0.3 μM (dashed line) or 1 μM (solid line) ABT-737. C, NALM-6 and RS4;11 cells were incubated with 0.1 μM (dashed line) or 1 μM (solid line) thapsigargin for 6 or 24 h. Cells were stained with TMRE or anti-cytochrome c and analyzed by flow cytometry. The gray-shaded histograms show TMRE staining intensity or cytochrome c detection in untreated cells. Results are representative of three separate experiments.
Fig. 8.
Fig. 8.
sHA 14-1-induced cell death is largely caspase-independent. RS4;11 cells were incubated with DMSO, 50 μM Z-VAD-fmk alone, 100 μM isHA 14-1, 1 μM TG, 100 μM sHA 14-1, 100 μM sHA 14-1 + 50 μM Z-VAD-fmk, 100 nM ABT-737, or 100 nM ABT-737 + 50 μM Z-VAD-fmk. After 18 h, cells were stained with PI and Annexin V. The data are shown as the light-scatter characteristics on the left side of each condition tested and the PI/Annexin V (ANV) staining as contour plots on the right side of each condition tested. PI/Annexin V analysis was conducted on the cells outlined by the solid line in the light scatter dot plots. The events within the dashed circles in the sHA 14-1- and ABT-737-treated cells are shown to distinguish the difference in light scatter characteristics between the two treated populations. FSC, forward scatter; SSC, side scatter.

References

    1. Adams JM and Cory S (2007) The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26 1324-1337. - PMC - PubMed
    1. An J, Chen Y, and Huang Z (2004) Critical upstream signals of cytochrome c release induced by a novel Bcl-2 inhibitor. J Biol Chem 279 19133-19140. - PubMed
    1. An J, Chervin AS, Nie A, Ducoff HS, and Huang Z (2007) Overcoming the radioresistance of prostate cancer cells with a novel Bcl-2 inhibitor. Oncogene 26 652-661. - PubMed
    1. Bilmen JG and Michelangeli F (2002) Inhibition of the type 1 inositol 1,4,5-trisphosphate receptor by 2-aminoethoxydiphenylborate. Cell Signal 14 955-960. - PubMed
    1. Birmachu W, Nisswandt FL, and Thomas DD (1989) Conformational transitions in the calcium adenosinetriphosphatase studied by time-resolved fluorescence resonance energy transfer. Biochemistry 28 3940-3947. - PubMed

Publication types

MeSH terms

Substances